Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simó Schwartz

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Oncogene|December 12, 2003
BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiencyCarla Oliveira, Mafalda Pinto, Alex Duval, et al.
International Journal of Pharmaceutics|July 15, 2014
Intracellular targeting of CD44+ cells with self-assembling, protein only nanoparticlesMireia Pesarrodona, Neus Ferrer-Miralles, Ugutz Unzueta, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Semisynthesis, cytotoxic activity, and oral availability of new lipophilic 9-substituted camptothecin derivativesGuillermo Rodriguez-Berna, Maria Jose Díaz Cabañas, Victor Mangas-Sanjuán, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 12, 2017
Improved pharmacokinetic profile of lipophilic anti-cancer drugs using ανβ3-targeted polyurethane-polyurea nanoparticlesPau Rocas, Yolanda Fernández, Natalia García-Aranda, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2005
The prevalence of PIK3CA mutations in gastric and colon cancerSérgia Velho, Carla Oliveira, Ana Ferreira, et al.
Nanomedicine (London, England)|June 23, 2021
Pluronic F127 micelles improve the stability and enhance the anticancer stem cell efficacy of citral in breast cancerMarwa M Abu-Serie, Fernanda Andrade, Patricia Cámara-Sánchez, et al.
Nanomaterials (Basel, Switzerland)|August 12, 2023
Nanoceria as Safe Contrast Agents for X-ray CT ImagingAna García, Juan Antonio Cámara, Ana María Boullosa, et al.
Plos Genetics|June 12, 2013
RSR-2, the Caenorhabditis elegans ortholog of human spliceosomal component SRm300/SRRM2, regulates development by influencing the transcriptional machineryLaura Fontrodona, Montserrat Porta-de-la-Riva, Tomás Morán, et al.
International Journal of Pharmaceutics|July 31, 2021
Thermo-responsive hydrogels for cancer local therapy: Challenges and state-of-artDiana Rafael, Maria Mercè Roca Melendres, Fernanda Andrade, et al.
Stem Cells International|November 9, 2018
Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer CellsPetra Gener, Joaquin Seras-Franzoso, Patricia González Callejo, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Oncogene|December 12, 2003
BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiencyCarla Oliveira, Mafalda Pinto, Alex Duval, et al.
International Journal of Pharmaceutics|July 15, 2014
Intracellular targeting of CD44+ cells with self-assembling, protein only nanoparticlesMireia Pesarrodona, Neus Ferrer-Miralles, Ugutz Unzueta, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Semisynthesis, cytotoxic activity, and oral availability of new lipophilic 9-substituted camptothecin derivativesGuillermo Rodriguez-Berna, Maria Jose Díaz Cabañas, Victor Mangas-Sanjuán, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 12, 2017
Improved pharmacokinetic profile of lipophilic anti-cancer drugs using ανβ3-targeted polyurethane-polyurea nanoparticlesPau Rocas, Yolanda Fernández, Natalia García-Aranda, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2005
The prevalence of PIK3CA mutations in gastric and colon cancerSérgia Velho, Carla Oliveira, Ana Ferreira, et al.
Nanomedicine (London, England)|June 23, 2021
Pluronic F127 micelles improve the stability and enhance the anticancer stem cell efficacy of citral in breast cancerMarwa M Abu-Serie, Fernanda Andrade, Patricia Cámara-Sánchez, et al.
Nanomaterials (Basel, Switzerland)|August 12, 2023
Nanoceria as Safe Contrast Agents for X-ray CT ImagingAna García, Juan Antonio Cámara, Ana María Boullosa, et al.
Plos Genetics|June 12, 2013
RSR-2, the Caenorhabditis elegans ortholog of human spliceosomal component SRm300/SRRM2, regulates development by influencing the transcriptional machineryLaura Fontrodona, Montserrat Porta-de-la-Riva, Tomás Morán, et al.
International Journal of Pharmaceutics|July 31, 2021
Thermo-responsive hydrogels for cancer local therapy: Challenges and state-of-artDiana Rafael, Maria Mercè Roca Melendres, Fernanda Andrade, et al.
Stem Cells International|November 9, 2018
Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer CellsPetra Gener, Joaquin Seras-Franzoso, Patricia González Callejo, et al.
Pageof 7